financetom
Business
financetom
/
Business
/
RB Global Q1 Adjusted EPS Falls, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RB Global Q1 Adjusted EPS Falls, Revenue Rises
May 26, 2025 3:05 AM

04:32 PM EDT, 05/07/2025 (MT Newswires) -- RB Global ( RBA ) reported Q1 adjusted earnings late Wednesday of $0.89 per diluted share, down from $0.90 a year earlier.

Analysts polled by FactSet expected $0.86.

Revenue for the quarter ended March 31 was $1.11 billion, up from $1.06 billion a year earlier.

Analysts surveyed by FactSet expected $1.06 billion.

RB Global ( RBA ) kept its quarterly cash dividend at $0.29 per share, payable June 20 to holders of record as of May 29.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NextDecade Unit Rio Grande LNG Issues $1.12 Billion of Notes Due 2047
NextDecade Unit Rio Grande LNG Issues $1.12 Billion of Notes Due 2047
Jul 1, 2024
09:22 AM EDT, 07/01/2024 (MT Newswires) -- NextDecade ( NEXT ) said Monday its Rio Grande LNG unit has issued about $1.12 billion of senior secured notes in a private placement. These notes will pay interest at a fixed rate of 6.58%, the company said. The notes, which will be amortized over an 18-year period starting in September 2029, have...
Pitney Bowes Increases Cost Rationalization Program's Savings Targets
Pitney Bowes Increases Cost Rationalization Program's Savings Targets
Jul 1, 2024
09:22 AM EDT, 07/01/2024 (MT Newswires) -- Pitney Bowes ( PBI ) said Monday that it has increased its cost rationalization program's savings targets to between $120 million and $160 million from an initial target of $60 million to $100 million. The company said management has identified more opportunities to achieve new efficiencies in the coming months. Pitney Bowes (...
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz
Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz
Jul 1, 2024
09:19 AM EDT, 07/01/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Monday that a US District Court in Delaware has allowed its patent lawsuit against Teva Pharmaceuticals USA and Apotex to proceed. The lawsuit, which was filed in December 2022, alleges that Teva and Apotex infringed Vanda's patent related to its sleep disorder medicine Hetlioz. Vanda said it...
Lifecore Biomedical Agrees to Add 4 Board Members Under 22NW Deal to Avoid Proxy Fight
Lifecore Biomedical Agrees to Add 4 Board Members Under 22NW Deal to Avoid Proxy Fight
Jul 1, 2024
09:17 AM EDT, 07/01/2024 (MT Newswires) -- Lifecore Biomedical ( LFCR ) said Monday that it has agreed to appoint four new members to its board under a cooperation agreement with investor group 22NW to avoid a proxy fight. The pharmaceutical products manufacturer said the new 22NW-nominated directors, Humberto Antunes, Jason Aryeh, Paul Johnson, and Matthew Korenberg, will join immediately...
Copyright 2023-2026 - www.financetom.com All Rights Reserved